Published on: 2026-11-02
Source: Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
Deputy Prime Minister Tatyana Golikova welcomed the participants and guests of the 5th National Congress with international participation “National Healthcare.”
“For about 20 years, our country’s healthcare system has been developing thanks to the systematization and establishment of priorities through national projects and government programs. We see the results. The volume of financial support for the basic Mandatory Health Insurance (MHI) program during this period has increased almost 23 times—from 219 billion to 5 trillion rubles. Infrastructure is being renewed and modernized in all regions of the country, taking into account the population’s needs and transport accessibility, and the human resource potential is developing. The work continues, but it is important to look to the future and build new approaches in the industry’s work,” said Tatyana Golikova.
She emphasized that at the end of last year, the country’s President approved a new Strategy for Healthcare Development in the Russian Federation for the period up to 2030, and a plan for its implementation was adopted. These documents are aimed at ensuring national security in the healthcare sector – improving the quality of medical care, increasing its accessibility, respecting citizens’ rights and providing state guarantees, and ensuring technological sovereignty. They link the completed national project “Healthcare” with new national projects “Prolonged and Active Life”, “Family”, “New Technologies for Health Preservation” into a single logic, ensuring continuity of activities and indicators.
In her speech, Tatyana Golikova focused on the key tasks.
First. The strategy is aimed at achieving the national goal defined by the head of state — to ensure a life expectancy of 78 years by 2030 and to reach the threshold exceeding 80 years by 2036, with an outpacing growth of expected healthy life expectancy. This means a shift in focus from treating already manifested diseases to identifying pre-risks and risks of disease development and their timely correction.
“A new development track in healthcare is being implemented – medicine for healthy longevity. The creation of centers for medicine of healthy longevity, personalized consultations on health management, and monitoring of aging mechanisms must be integrated into everyday life. The task of the regions is to create infrastructure and organize operations so that a person of any age can receive a personalized track for maintaining health, rather than just the recommendation ‘take care of yourself’,” emphasized the Deputy Prime Minister.
Second. Creating conditions to improve the quality and safety of medical care, increase its accessibility, as well as to enhance public trust in the healthcare system. New diagnostic methods are introduced into practical healthcare every year, ranging from rapid infection tests to the use of radiopharmaceuticals; biomedical cellular products and regenerative medicine technologies are being developed.
The availability of unique treatment methods is increasing. For several years, the state guarantee program has included a list of unique surgical treatment methods, which is expanded and extended annually. From this year, the program has been supplemented with types of high-tech medical care using a number of personalized treatment methods, the list of which will be further expanded from 2027, including new technologies for treating oncological diseases. Among them are anti-tumor therapy using personalized mRNA vaccines developed based on the molecular-genetic characteristics of a specific patient’s tumor; anti-tumor therapy for metastatic colorectal cancer with the personalized peptide vaccine “Oncopept”; T-cell immunotherapy using genetically modified autologous T-lymphocytes with chimeric antigen receptor CAR-T.
The approach to the functioning of national medical research centers has been changed. The status of a “lifetime” NMRC no longer exists. According to the new selection rules, the NMRC status can be awarded provided the criteria for scientific research, publications, and quality of medical care are met.
“NMICs can no longer be limited to the role of a leading institution that issues recommendations. Their real value is measured by the help they have provided to the regions and how much they have improved performance indicators in their profile. Trips to the regions have become mandatory,” said the Deputy Prime Minister.
Third. The problem of staff imbalance persists. And here the main thing is the assessment and improvement of labor productivity. It is necessary to continuously evaluate the workload on medical workers taking into account the standards established by the Ministry of Health of Russia.
Fourth. Ensuring technological sovereignty through the production of domestic pharmaceutical drugs and medical devices, the development of modern medical technologies. First and foremost, this concerns biotechnological drugs and medical devices, biomedical cellular products, regenerative and nuclear medicine, digital and preventive technologies.
“By 2030, we must achieve a technological sovereignty level of 80%. By the end of 2025, the indicator for the national project ‘New Health-Saving Technologies’ will be fully achieved, but the main result is not in the numbers, but in new medicines, medical devices, and specific treatment methods that change patients’ quality of life. It is important that new medicines and medical devices are promptly included in clinical guidelines and find application in practical healthcare,” noted Tatiana Golikova.
By 2030, 90% of all drugs on the list of essential medicines and 40% of medical devices used must be of Russian manufacture.
According to Tatyana Golikova, today the country already produces 40 international nonproprietary names ( INN) Medicinal products from the list of vital and essential drugs that were not previously produced in our country. In 2026 alone, 15 INNs were registered for the treatment of oncological diseases, multiple sclerosis, rheumatoid arthritis, and other conditions. In 2025–2026, 1,812 medical devices were “given a start in life.” By the end of 2030, 3,400 domestic medical devices are expected to be produced.
Fifth – development of digital technologies in healthcare.
“This is not only about digital twins of doctors or patients, scheduling appointments, and transmitting medical documents electronically. It is primarily about proactive monitoring of the population’s health status, telemedicine consultations, and support for medical decisions using artificial intelligence. All of this is intended to help specialists identify changes in patients’ health and free up medical personnel’s time to ensure a personalized approach to each individual. It is important for us to provide a unified medical record for the patient, where a doctor can see the entire medical history of the person who comes to them on their computer, rather than collecting the anamnesis anew and reviewing the extracts and conclusions brought by the patient. This is a significant task for both the Russian Ministry of Health and the Federal Mandatory Medical Insurance Fund, as well as for the regions,” emphasized Tatyana Golikova.
Please note; This information is raw content obtained directly from the information source. It represents an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.